PRIMARY STUDY

Bladder Cancer Cell Growth and Motility Implicate Cannabinoid 2 Receptor-Mediated Modifications of Sphingolipids Metabolism

Key Findings:  Human bladder cancer cell lines (RT4, RT112) were treated with CB agonists to assess proliferation, apoptosis, and motility. The CB2 agonist JWH-015 induced anti-proliferative activity and inhibited bladder cancer cell growth.

Type of Study:  Laboratory Study

Study Result:  Positive

Study Location(s):  Italy, Sweden, United States

Year of Pub:  2017


Cannabinoids Studied:  JWH-x Synthetic Cannabinoids

Phytocannabinoid Source:  Not Applicable

Receptors Studied:  CB2

Route of Administration:  In vitro



Link to study